GINA ACCURSO-LEE: Open Payments
NPI 1598381279 · HARRISONVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,594 in 100 payments from 8 companies in 2025. Trend: 2023 $1,981 · 2024 $1,870 · 2025 $1,594
Food & beverage: $1,594
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $596 |
| Amgen Inc. | 26 | $275 |
| Novartis Pharmaceuticals Corporation | 12 | $191 |
| UCB, Inc. | 11 | $175 |
| GlaxoSmithKline, LLC. | 7 | $119 |
| Janssen Biotech, Inc. | 4 | $88 |
| E.R. Squibb & Sons, L.L.C. | 4 | $82 |
| PFIZER INC. | 3 | $68 |
Products named: RINVOQ, OTEZLA, SKYRIZI, Bimzelx, COSENTYX, BENLYSTA, TREMFYA, ORENCIA.
Industry payments across MO — which companies pay providers there.
